COMMON SHARE PURCHASE WARRANTCommon Share Purchase Warrant • July 2nd, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Platinum Point Capital LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 4, 2024 (as defined in the Purchase Agreement) has been received (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of such Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Mangoceuticals, Inc., a corporation incorporated under the laws of the State of Texas (the “Company”), up to 500,000 (as subject to adjustment hereunder, the “Warrant Shares”) Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
OMNIBUS AMENDMENT AGREEMENT NO. 1Omnibus Amendment Agreement • July 2nd, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec
This Omnibus Amendment Agreement No. 1 (this “Amendment”), dated and effective as of June 27, 2024, by and between Mangoceuticals, Inc. (the “Corporation” or “Company”), a corporation organized under the laws of the State of Texas (the “Company”), and Platinum Point Capital LLC (including its successors and assigns, the “Purchaser”).
